Selectis Health Changes Auditors
Ticker: GBCS · Form: 8-K · Filed: Dec 9, 2024 · CIK: 727346
| Field | Detail |
|---|---|
| Company | Selectis Health, Inc. (GBCS) |
| Form Type | 8-K |
| Filed Date | Dec 9, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, accounting
TL;DR
Selectis Health dumped BDO USA and hired Armanino LLP as their new auditor.
AI Summary
Selectis Health, Inc. announced on December 4, 2024, a change in its certifying accountant. The company has dismissed BDO USA, P.A. as its independent registered public accounting firm and has appointed Armanino LLP as its new independent registered public accounting firm, effective immediately.
Why It Matters
A change in auditors can sometimes signal underlying issues or a desire for a fresh perspective on financial reporting, which investors should monitor.
Risk Assessment
Risk Level: medium — Changes in auditors can sometimes precede or coincide with financial restatements or other disclosures that may impact the company's stock price.
Key Players & Entities
- Selectis Health, Inc. (company) — Registrant
- BDO USA, P.A. (company) — Former Certifying Accountant
- Armanino LLP (company) — New Certifying Accountant
- December 4, 2024 (date) — Date of earliest event reported
FAQ
Why was BDO USA, P.A. dismissed as Selectis Health's certifying accountant?
The filing states that the dismissal was "by the Company" and does not provide a specific reason for the change.
When was Armanino LLP appointed as the new certifying accountant?
Armanino LLP was appointed as the new independent registered public accounting firm, effective immediately, on December 4, 2024.
Did Selectis Health have any disagreements with BDO USA, P.A. that led to the dismissal?
The filing explicitly states that there were no disagreements between Selectis Health and BDO USA, P.A. on any matter of accounting principles or financial statement disclosure.
What is the effective date of the change in certifying accountant?
The change is effective immediately as of December 4, 2024.
Has Selectis Health previously engaged Armanino LLP for any services?
The filing does not mention any prior engagement of Armanino LLP by Selectis Health.
Filing Stats: 392 words · 2 min read · ~1 pages · Grade level 13.3 · Accepted 2024-12-09 14:23:04
Filing Documents
- form8-k.htm (8-K) — 34KB
- 0001493152-24-049235.txt ( ) — 201KB
- gbcs-20241204.xsd (EX-101.SCH) — 3KB
- gbcs-20241204_lab.xml (EX-101.LAB) — 33KB
- gbcs-20241204_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
From the Filing
UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Number (I.R.S. Employer Identification number) 8480 E. Orchard Road , Ste. 4900 , Greenwood Village , CO 80111 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (720) 680-0808 (Former name or former address, if changed since last report) Written communications pursuant to Rule 425 under the Securities Act Soliciting material pursuant to Rule 14a-12 under the Exchange Act Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act Securities registered pursuant to Section 12(b) of the Act: Title of each Class Trading Symbol Name of each exchange on which registered N/A N/A N/A Indicate by check mark whether the registrant is an emerging growth company as dened in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised nancial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 4.01 CHANGES IN REGISTRANT'S INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS Effective December 4, 2024, the Company's Board of Directors, at the recommendation of the Audit Committee that has been separately appointed, approved the appointment of WithumSmith+Brown, PC ("Withum") to serve as the Company's independent registered public accounting firm. Prior to its engagement as the Company's independent registered public accounting firm the Company had not consulted Withum with respect to the application of accounting principles to specific transactions or the type of audit opinion that might be rendered on the Company's financial statements. ITEM 9.01 EXHIBITS None SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. SELECTIS HEALTH, INC. Registrant Dated: December 9, 2024 /s/ Adam Desmond Adam Desmond, CEO